Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China
The 2024 revised criteria introduced an integrated framework for staging Alzheimer disease (AD) across biological and clinical dimensions. However, how this criterion characterizes clinical and biological features in populations outside the original development setting, particularly in non-Western and specialized clinic settings, remains insufficiently described.
Authors
- Mingyu Wang (ORCID: https://orcid.org/0000-0002-5161-3814)
- Jin‐Tai Yu (ORCID: https://orcid.org/0000-0002-7686-0547)
- Shufen Chen (ORCID: https://orcid.org/0000-0003-0333-958X)
- Wei Cheng (ORCID: https://orcid.org/0000-0003-1118-1743)
- Mei Cui (ORCID: https://orcid.org/0000-0002-6449-8106)
- Jiaying Lu (ORCID: https://orcid.org/0000-0003-0927-0042)
- Chuantao Zuo (ORCID: https://orcid.org/0000-0002-8856-7217)
- 王荣泽
- Wei Zhang (ORCID: https://orcid.org/0000-0001-7800-3189)
- Xiaochun Chen (ORCID: https://orcid.org/0000-0002-2665-4155)
- Wenjing Huang (ORCID: https://orcid.org/0000-0003-3775-3228)
- Zi-yi Wang
- Jia-Wei Xin
- Y Huang (ORCID: https://orcid.org/0009-0005-3406-4875)
- Qianhua Zhao
- Keliang Chen
- Fang Xie
Institutions
- Qingdao University (CN)
- Fujian Medical University (CN)
- Qingdao Agricultural University (CN)
- Shandong University (CN)
- Weifang People's Hospital (CN)
- Huashan Hospital (CN)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
Publication Details
- Journal
- Neurology
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1212/wnl.0000000000218184
- Citations
- 1
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 11.09